ASX - By Stock
|
SPL |
Re:
Ann: Targeted DEP shows sustained superior performance
|
|
maslow
|
5 |
2.2K |
4 |
02/02/16 |
02/02/16 |
ASX - By Stock
|
5
|
2.2K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
maslow
|
29 |
7.8K |
2 |
21/01/16 |
21/01/16 |
ASX - By Stock
|
29
|
7.8K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
maslow
|
29 |
7.8K |
0 |
20/01/16 |
20/01/16 |
ASX - By Stock
|
29
|
7.8K
|
0
|
|
ASX - By Stock
|
IPD |
Great start today
|
|
maslow
|
5 |
1.8K |
5 |
20/01/16 |
20/01/16 |
ASX - By Stock
|
5
|
1.8K
|
5
|
|
ASX - By Stock
|
HYD |
CES - Toxicity monitors
|
|
maslow
|
39 |
9.0K |
1 |
16/01/16 |
16/01/16 |
ASX - By Stock
|
39
|
9.0K
|
1
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Medical Advisory Board for Chronic Heart Failure Established
|
|
maslow
|
16 |
4.2K |
2 |
11/01/16 |
11/01/16 |
ASX - By Stock
|
16
|
4.2K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Ann: PolyNovo's US FDA approval
|
|
maslow
|
41 |
13K |
2 |
29/12/15 |
29/12/15 |
ASX - By Stock
|
41
|
13K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Ann: PolyNovo's US FDA approval
|
|
maslow
|
41 |
13K |
2 |
29/12/15 |
29/12/15 |
ASX - By Stock
|
41
|
13K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Ann: PolyNovo's US FDA approval
|
|
maslow
|
41 |
13K |
1 |
29/12/15 |
29/12/15 |
ASX - By Stock
|
41
|
13K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
Ann: PolyNovo's US FDA approval
|
|
maslow
|
41 |
13K |
1 |
29/12/15 |
29/12/15 |
ASX - By Stock
|
41
|
13K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
looks to be building for a run
|
|
maslow
|
34 |
15K |
4 |
15/12/15 |
15/12/15 |
ASX - By Stock
|
34
|
15K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trofinetide successful in Phase 2 trial in Fragile X
|
|
maslow
|
103 |
67K |
2 |
14/12/15 |
14/12/15 |
ASX - By Stock
|
103
|
67K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Bellpotter
|
|
maslow
|
32 |
19K |
0 |
07/12/15 |
07/12/15 |
ASX - By Stock
|
32
|
19K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Here's a ramp
|
|
maslow
|
7 |
2.7K |
2 |
07/12/15 |
07/12/15 |
ASX - By Stock
|
7
|
2.7K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
The best bit...... Autism should be next
|
|
maslow
|
3 |
1.6K |
4 |
07/12/15 |
07/12/15 |
ASX - By Stock
|
3
|
1.6K
|
4
|
|
ASX - By Stock
|
NEU |
The best bit...... Autism should be next
|
|
maslow
|
3 |
1.6K |
21 |
07/12/15 |
07/12/15 |
ASX - By Stock
|
3
|
1.6K
|
21
|
|
Charts
|
IPD |
Re:
Commercial launch
|
|
maslow
|
20 |
4.6K |
2 |
03/12/15 |
03/12/15 |
Charts
|
20
|
4.6K
|
2
|
|
ASX - By Stock
|
HYD |
Re:
'material licensing agreement''''''
|
|
maslow
|
93 |
26K |
8 |
25/11/15 |
25/11/15 |
ASX - By Stock
|
93
|
26K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Preclinical Studies Justify Mode of Delivery for Anisina
|
|
maslow
|
37 |
7.8K |
3 |
11/11/15 |
11/11/15 |
ASX - By Stock
|
37
|
7.8K
|
3
|
|
ASX - By Stock
|
HYD |
Re:
Great article in todays oz
|
|
maslow
|
132 |
41K |
13 |
03/09/15 |
03/09/15 |
ASX - By Stock
|
132
|
41K
|
13
|
|
ASX - By Stock
|
HYD |
Great article in todays oz
|
|
maslow
|
132 |
41K |
1 |
03/09/15 |
03/09/15 |
ASX - By Stock
|
132
|
41K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Anisina Orphan Drug Designation!
|
|
maslow
|
42 |
9.8K |
13 |
16/07/15 |
16/07/15 |
ASX - By Stock
|
42
|
9.8K
|
13
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Studies Confirm TRXE-009 Kills Paediatric Brain Cancer Cells
|
|
maslow
|
147 |
42K |
3 |
08/05/15 |
08/05/15 |
ASX - By Stock
|
147
|
42K
|
3
|
|
ASX - By Stock
|
KZA |
Malignat Ascites - Will Cantrixil be first?
|
|
maslow
|
0 |
317 |
1 |
22/04/15 |
22/04/15 |
ASX - By Stock
|
0
|
317
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Nasdaq 21/4
|
|
maslow
|
99 |
33K |
1 |
22/04/15 |
22/04/15 |
ASX - By Stock
|
99
|
33K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Nasdaq 21/4
|
|
maslow
|
99 |
33K |
1 |
22/04/15 |
22/04/15 |
ASX - By Stock
|
99
|
33K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Cantrixil--Orphan Drug Designation
|
|
maslow
|
8 |
3.2K |
4 |
22/04/15 |
22/04/15 |
ASX - By Stock
|
8
|
3.2K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Channel 7 News
|
|
maslow
|
35 |
9.3K |
0 |
18/03/15 |
18/03/15 |
ASX - By Stock
|
35
|
9.3K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Channel 7 News
|
|
maslow
|
35 |
9.3K |
0 |
18/03/15 |
18/03/15 |
ASX - By Stock
|
35
|
9.3K
|
0
|
|
ASX - By Stock
|
SRX |
Re:
Ann: Preliminary SIRFLOX Study Results
|
|
maslow
|
52 |
30K |
1 |
17/03/15 |
17/03/15 |
ASX - By Stock
|
52
|
30K
|
1
|
|
ASX - By Stock
|
SRX |
Re:
Ann: Preliminary SIRFLOX Study Results
|
|
maslow
|
52 |
30K |
0 |
17/03/15 |
17/03/15 |
ASX - By Stock
|
52
|
30K
|
0
|
|
ASX - By Stock
|
HYD |
Re:
announcement
|
|
maslow
|
43 |
16K |
1 |
13/03/15 |
13/03/15 |
ASX - By Stock
|
43
|
16K
|
1
|
|
ASX - By Stock
|
HYD |
Re:
announcement
|
|
maslow
|
43 |
16K |
8 |
13/03/15 |
13/03/15 |
ASX - By Stock
|
43
|
16K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
keeping it real - facts only
|
|
maslow
|
204 |
44K |
1 |
27/02/15 |
27/02/15 |
ASX - By Stock
|
204
|
44K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
keeping it real - facts only
|
|
maslow
|
204 |
44K |
1 |
27/02/15 |
27/02/15 |
ASX - By Stock
|
204
|
44K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Still only $85m market cap ....
|
|
maslow
|
43 |
9.8K |
1 |
27/02/15 |
27/02/15 |
ASX - By Stock
|
43
|
9.8K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
is cyp the next msb?
|
|
maslow
|
89 |
29K |
2 |
26/02/15 |
26/02/15 |
ASX - By Stock
|
89
|
29K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Strong in the US
|
|
maslow
|
48 |
11K |
0 |
18/02/15 |
18/02/15 |
ASX - By Stock
|
48
|
11K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Strong in the US
|
|
maslow
|
48 |
11K |
0 |
18/02/15 |
18/02/15 |
ASX - By Stock
|
48
|
11K
|
0
|
|
ASX - By Stock
|
GTG |
Re:
Good buying
|
|
maslow
|
34 |
12K |
2 |
16/02/15 |
16/02/15 |
ASX - By Stock
|
34
|
12K
|
2
|
|
ASX - By Stock
|
GTG |
Re:
Buyers lining up pre market!
|
|
maslow
|
30 |
11K |
0 |
16/02/15 |
16/02/15 |
ASX - By Stock
|
30
|
11K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
FDA Grants Orphan Drug Designation
|
|
maslow
|
54 |
31K |
2 |
16/02/15 |
16/02/15 |
ASX - By Stock
|
54
|
31K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
FDA Grants Orphan Drug Designation
|
|
maslow
|
54 |
31K |
5 |
14/02/15 |
14/02/15 |
ASX - By Stock
|
54
|
31K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
FDA Grants Orphan Drug Designation
|
|
maslow
|
54 |
31K |
1 |
14/02/15 |
14/02/15 |
ASX - By Stock
|
54
|
31K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
FDA Grants Orphan Drug Designation
|
|
maslow
|
54 |
31K |
8 |
14/02/15 |
14/02/15 |
ASX - By Stock
|
54
|
31K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
Ann: FDA End-of Phase 2 Status Update
|
|
maslow
|
103 |
33K |
5 |
13/02/15 |
13/02/15 |
ASX - By Stock
|
103
|
33K
|
5
|
|
ASX - By Stock
|
GTG |
90,000.000 women in US aged 25-70 census 2012
|
|
maslow
|
11 |
2.9K |
1 |
13/02/15 |
13/02/15 |
ASX - By Stock
|
11
|
2.9K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: FDA End-of Phase 2 Status Update
|
|
maslow
|
103 |
33K |
6 |
13/02/15 |
13/02/15 |
ASX - By Stock
|
103
|
33K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Closing action
|
|
maslow
|
33 |
16K |
7 |
12/02/15 |
12/02/15 |
ASX - By Stock
|
33
|
16K
|
7
|
|
ASX - By Stock
|
GTG |
Re:
GTG v GENE...... Who's holding the tail
|
|
maslow
|
6 |
2.3K |
2 |
11/02/15 |
11/02/15 |
ASX - By Stock
|
6
|
2.3K
|
2
|
|